Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis

BACKGROUND: Both angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are blood pressure-lowering agents, but they are also being used to control proteinuria in early chronic kidney disease (CKD) patients. However, clinically, some patients present merely protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Huizhen, Huo, Zhihao, Ye, Peiyi, Xiao, Guanqing, Zhang, Zhe, Xie, Chao, Kong, Yaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073241/
https://www.ncbi.nlm.nih.gov/pubmed/32201639
http://dx.doi.org/10.7717/peerj.8575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073241/
https://www.ncbi.nlm.nih.gov/pubmed/32201639
http://dx.doi.org/10.7717/peerj.8575

Ejemplares similares